![]() |
市场调查报告书
商品编码
1660062
骨超音波仪市场:现状分析与未来预测 (2024年~2032年)Bone Sonometers Market: Current Analysis and Forecast (2024-2032) |
预计预测期内(2024-2032 年),骨超音波仪市场将以 5.7% 的复合年增长率大幅增长。骨密度仪市场的发展受到骨质疏鬆症和相关骨折发病率上升以及老年人群体对经济有效的骨密度评估方法的需求的推动。骨骼相关疾病预防医学的进步给各类医疗保健提供者带来了压力,迫使他们采用骨超音波仪等非侵入性、便携性、无辐射的设备。用于诊断影像的超音波诊断技术的新技术以及从集中式实验室测试到更接近患者的转变也在推动市场成长。
根据设计,市场分为两个部分:固定式骨超音波仪和携带式骨超音波仪。其中,固定式骨超音波仪目前比携带式骨超音波仪占有更大的市场占有率。这主要是因为固定设备广泛用于医院、诊所和诊断中心,而这些地方精确、准确的骨密度测量至关重要。便携式骨密度仪具有更多功能和准确性,非常适合在复杂的诊断环境中使用。然而,预计便携式骨超音波仪在未来将呈现显着的成长。鑑于当前医疗保健系统追求的可及性和便利性,便携式设备因其简便、低成本、以及能够在不同或独特的护理环境中进行初步筛检而逐渐被采用。
根据应用,市场分为四大类:骨质疏鬆症筛检、骨折风险评估、骨骼健康监测等。其中,骨质疏鬆筛检领域处于领先地位,占据骨超音波仪市场的最大占有率。这种主导地位是由于骨质疏鬆症已成为一个全球性问题,特别是在老年人和停经后妇女中盛行。由于早期发现骨质疏鬆症对于预防骨折是必要的,而且近年来人们对骨质疏鬆症的认识有所提高,因此骨超音波仪被用于大规模筛检。庞大的老年人口、政府和医疗部门积极开展的与骨质疏鬆症相关的活动以及筛检计画的推出,正在加强这一领域的市场地位。
根据最终用户,市场分为医院、门诊手术中心、诊所和其他。其中,医院部门目前占据骨超音波仪市场的主导地位。医院作为卫生系统的大型单位,是有效诊断、管理和治疗的单一联络点,包括骨质疏鬆症筛检、病患骨折风险评估、骨骼健康监测和其他相关问题。由于医院拥有专业知识、强大的基础设施和较高的患者流动率,因此是骨超音波仪的主要分销管道。此外,医院也定期为政府医疗计画和各类筛检活动提供服务,进一步增强了其产业优势。
为了更了解骨声学仪的市场渗透率,我们根据北美(美国、加拿大和北美其他地区)、欧洲(德国、法国、英国、西班牙、义大利和欧洲其他地区)、亚太地区(中国、日本、印度和亚太地区其他地区)和世界其他地区的全球影响力进行分析。由于骨质疏鬆症盛行率不断上升,尤其是在印度和中国等国家,预计预测期内(2024-2032 年)亚太地区将以显着的复合年增长率成长。骨超音波仪市场强调协作开发活动以改善产品开发。
市场的主要参与者包括GE HealthCare Technologies Inc.,CyberLogic, inc.,徐州Pinyuan Electronic Technology Co., Ltd.,Echolight S.p.a.,FURUNO ELECTRIC CO. LTD,Osteosys,BeamMed Ltd.,SonicBone,BMTech Co., Ltd.,Life Medical Equipment Co., Ltd.等。
A bone sonometer is an instrument that diagnoses or supervises bone density and bone quality. it is generally applied for diagnosing illnesses such as osteoporosis. They work on the basis of ultrasonic waves, which determine how these waves propagate through bones. This examination makes use of two characteristic indices, namely the Speed of Sound (SOS) and Broadband Ultrasound Attenuation (BUA) in an effort to assess bone status. It is measured against some normative values based on the age and sex of the patient; denser and healthier bones are better transmitters of sound waves. Bone sonometers are typically applied to peripheral areas of the body, for example, on the heel (calcaneum), fingers, or forearm. As compared to methods like DEXA bone density measurement, bone sonometers are portable, non-ionizing, less expensive, and therefore suitable as a first-line assessment and in clinical areas where DEXA is inaccessible. Although less accurate than the DEXA scans, they enable easy determination of subjects at risk of fractures or assessment of changes in bone density over time.
The Bone Sonometers Market is expected to grow with a significant CAGR of 5.7% during the forecast period (2024-2032). The bone sonometers market has been propelled by the rising incidences of osteoporosis and related fractures, and the elderly population's need for cost-effective and effective methods of bone density assessment. Advancements in preventive care with regard to bone-related diseases are putting pressure on various care providers to embrace non-invasive, portable, and radiation-free equipment such as bone sonometers. New technologies in ultrasonic diagnostic technology for imaging and the shift from centralized laboratory testing to near-patient testing are also propelling the market's growth.
Based on the design, the market is segmented into two categories, stationary bone sonometers and portable bone sonometers. Among these, stationary bone sonometer presently occupies a larger market share when compared with the portable bone sonometer segment. This is mainly due to the fact that stationary devices are extensively used in hospitals, clinics, and diagnostic centers where precision and accurate bone density measurements are essential. They provide far richer capabilities and accuracy that makes them ideal to use in highly functional diagnostic environments. However, it has been forecasted that the portable bone sonometer will show considerable future growth. Owing to access and convenience aspects pursued by current healthcare systems, portable devices are progressively gaining adoption because of their ease, low costs, and heightened ability to implement preliminary screening in different or distinct care circumstances.
According to the application, the market can be divided into 4 categories- osteoporosis screening, fracture risk assessment, monitoring bone health, and others. Out of these, the segmentation by the osteoporosis screening application is at the forefront, occupying the largest share in the bone sonometers market. This dominance is a result of the fact that osteoporosis is increasingly becoming a worldwide issue with special tendencies toward the aged and postmenopausal ladies. The need for early detection of osteoporosis in order to avoid fractures and the recent surge in awareness of the condition is making bone sonometers available for mass screening. The large population of elderly people, mass governmental and healthcare campaigns related to osteoporosis, and the beginning of screening programs augment the great market position of this segment.
Based on the end-user, the market has been segmented into hospitals, ambulatory surgical centers, clinics, and others. Out of these, the hospital segment is currently dominating the market of bone sonometers. As large units of healthcare systems, hospitals act as a single point of contact for effective diagnosis, management, and treatment, including osteoporosis screening and evaluation of patients' fracture risk, bone health monitoring, and other related problems. By virtue of its expertise, strong infrastructure, and high patient turnover, hospitals are the primary distribution channel for bone sonometers. Moreover, hospitals regularly engage in providing services for government healthcare programs and various screening campaigns that further enhance the industry's dominant position.
For a better understanding of the market penetration of bone sonometers market is analyzed based on its worldwide presence in regions such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR in the forecast period (2024-2032) owing to the growing incidence of osteoporosis, especially in countries like India and China. The emphasis is made on the development of collaboration activities to improve product development in the bone sonometer market.
Some of the major players operating in the market include GE HealthCare Technologies Inc., CyberLogic, inc., Xuzhou Pinyuan Electronic Technology Co., Ltd., Echolight S.p.a, Furuno Electric, Osteosys, BeamMed Ltd., SonicBone, BMTech Co., Ltd., Life Medical Equipment Co., Ltd.